Senior insider sale
EVP, Chf GL Pdt Str Ofcr at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$4.54M
60.08K shares
What this filing means
JENNE KYLE plans to sell 60.08K shares of IONIS PHARMACEUTICALS INC valued at approximately $4.54M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001972481-26-000093
Officer· EVP, Chf GL Pdt Str Ofcr
Since Mar 2026
60.08K
Shares to sell
$4.54M
Approx. market value
37.28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Option Exercise
Cash
1/2/2025
32.60KOption Exercise
Cash
2/26/2024
4.67KTotal acquired37.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2025 | Option Exercise Cash | 32.60K | — |
2/26/2024 | Option Exercise Cash | 4.67K | — |
| Total | 37.28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.82K
Market value
$139.0K
1/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
58.25K
Market value
$4.40M
3/10/2026
Total
Units
60.08K
Value
$4.54M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/16/2026 | 1.82K | $139.0K | — | Completed |
| Planned — Approximate Date | ||||
3/10/2026 | 58.25K | $4.40M | Nasdaq | Planned |
| Total | 60.08K | $4.54M | ||